PDS Biotechnology Corporation (PDSB)

NASDAQ

$0.72

PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. The company is headquartered in Florham Park, New Jersey.

Website: https://www.pdsbiotech.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $7.50 (+945.59%)

Market Cap

$42M

Free Cash Flow Yield

-55.46%

Beta (5Y)

1.88

Price Chart

Adjust inflation

Log

Valuation

Market Cap$42M

P/B10.59

Profitability

EBITDA-$29M

EPS-$0.17

Financial Health

Free Cash Flow Yield-55.46%

Growth & Risk

EPS 5Y CAGR-24.31%

FCF 5Y CAGR+10.87%

Beta (5Y)1.88

Sharpe Ratio-0.08